α7nAChR-mediated cholinergic anti-inflammatory pathway of immune cells in sepsis induced cardiac injury

Sepsis is a systemic syndrome characterized by widespread inflammatory responses induced by pathogenic microorganism invasion into the body, with increased suscep-tibility to major organs. Sepsis-induced cardiomyopathy is characterized by reversible myocardial depression or injury, primarily presenting as acute heart failure and/or arrhythmias triggered by sepsis. The mortality rate substantially increases when septic patients develop sepsis-induced cardiomyopathy. The cholinergic anti-inflammatory pathway (CAP) regulates inflammatory responses through the release of acetylcholine (ACh) via the vagus nerve and acts upon α7 nicotinic acetylcholine receptors (α7nAChR) on immune cells to suppress pro-inflammatory sytokines synthesis. In this review, we provide a concise overview of the current understanding of the α7nAChR-mediated CAP in sepsis-induced cardiac injury, with a primary focus on α7nAChR involvement in immune regulation.

α7nAChR; Mediated cholinergic anti-inflammatory pathway; Immune cells; Sepsis; Cardiac injury

[1] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801–810.

[2] Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J, Huertos-Ranchal MJ. Sepsis-induced cardiomyopathy. Current Cardiology Reviews. 2011; 7: 163–183.

[3] Martin L, Derwall M, Al Zoubi S, Zechendorf E, Reuter DA, Thiemermann C, et al. The septic heart: current understanding of molecular mechanisms and clinical implications. Chest. 2019; 155: 427–437.

[4] Wang H, Cui W, Qiao L, Hu G. Overexpression of miR-451a in sepsis and septic shock patients is involved in the regulation of sepsis-associated cardiac dysfunction and inflammation. Genetics and Molecular Biology. 2020; 43: e20200009.

[5] Zahradnicka M, Saudek F, Lipar K, Skibova J. Hypoglycemia and glucocorticoid-free immunosuppression are related with low dehydroepiandrosterone sulfate level. Endocrine, Metabolic & Immune Disorders Drug Targets. 2017; 17: 63–70.

[6] Fernandez R, Nardocci G, Navarro C, Reyes EP, Acuña-Castillo C, Cortes PP. Neural reflex regulation of systemic inflammation: potential new targets for sepsis therapy. Frontiers in Physiology. 2014; 5: 489.

[7] Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nature Reviews Drug Discovery. 2005; 4: 673–684.

[8] Boland C, Collet V, Laterre E, Lecuivre C, Wittebole X, Laterre P. Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats. Inflammation. 2011; 34: 29–35.

[9] Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Critical Care Medicine. 2007; 35: 2762–2768.

[10] Plummer HK 3rd, Dhar M, Schuller HM. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells. Respiratory Research. 2005; 6: 29.

[11] van Maanen MA, Stoof SP, van der Zanden EP, de Jonge WJ, Janssen RA, Fischer DF, et al. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis and Rheumatism. 2009; 60: 1272–1281.

[12] Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. The Journal of Pharmacology and Experimental Therapeutics. 1998; 287: 435–439.

[13] Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research. 2011; 221: 555–563.

[14] Zhang Q, Lu Y, Bian H, Guo L, Zhu H. Activation of the α7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2. American Journal of Translational Research. 2017; 9: 971–985.

[15] Wu CH, Inoue T, Nakamura Y, Uni R, Hasegawa S, Maekawa H, et al. Activation of α7 nicotinic acetylcholine receptors attenuates monocyte-endothelial adhesion through FUT7 inhibition. Biochemical and Biophysical Research Communications. 2022; 590: 89–96.

[16] Kong W, Kang K, Gao Y, Liu H, Meng X, Yang S, et al. Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. American Journal of Translational Research. 2017; 9: 5040–5047.

[17] Jiang Y, Ma H, Wang X, Wang Z, Yang Y, Li L, et al. Protective effect of the α7 nicotinic receptor agonist PNU-282987 on dopaminergic neurons against 6-hydroxydopamine, regulating anti-neuroinflammatory and the immune balance pathways in rat. Frontiers in Aging Neuroscience. 2021; 12: 606927.

[18] Schwaneck EC, Renner R, Junker L, Tony HP, Kleinert S, Gernert M, et al. T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy. Scandinavian Journal of Rheumatology. 2020; 49: 8–12.

[19] Nizri E, Hamra-Amitay Y, Sicsic C, Lavon I, Brenner T. Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology. 2006; 50: 540–547.

[20] Chen LR, Yang H, Liu L, Wang XX, Zhang XM, Wang HX. CD1d-dependent natural killer T-cells inactivation aggravates sepsis-induced myocardial injury via T lymphocytes infiltration and IL-6 production in mice. International Immunopharmacology. 2023; 120: 110256.

[21] Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, et al. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. Journal of Neuroimmunology. 2008; 203: 12–22.

[22] Wu YJ, Wang L, Ji CF, Gu SF, Yin Q, Zuo J. The role of α7nAChR-mediated cholinergic anti-inflammatory pathway in immune cells. Inflammation. 2021; 44: 821–834.

[23] Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. The Journal of Immunology. 2009; 183: 6681–6688.

[24] Gowayed MA, Rothe K, Rossol M, Attia AS, Wagner U, Baerwald C, et al. The role of α7nAChR in controlling the anti-inflammatory/anti-arthritic action of galantamine. Biochemical Pharmacology. 2019; 170: 113665.

[25] Kawashima K, Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Frontiers in Bioscience. 2004; 9: 2063–2085.

[26] Martini E, Kunderfranco P, Peano C, Carullo P, Cremonesi M, Schorn T, et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation. 2019; 140: 2089–2107.

[27] Skok MV, Kalashnik EN, Koval LN, Tsetlin VI, Utkin YN, Changeux JP, et al. Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Molecular Pharmacology. 2003; 64: 885–889.

[28] Skok M, Grailhe R, Changeux JP. Nicotinic receptors regulate B lymphocyte activation and immune response. European Journal of Pharmacology. 2005; 517: 246–251.

[29] Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA, et al. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Journal of Neuroimmunology. 2007; 189: 69–74.

[30] Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS−) vs. alternatively activated macrophages. Frontiers in Immunology. 2019; 10: 1084.

[31] de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nature Immunology. 2005; 6: 844–851.

[32] Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cellular and Molecular Life Sciences. 2011; 68: 931–949.

[33] Piovesana R, Salazar Intriago MS, Dini L, Tata AM. Cholinergic modulation of neuroinflammation: focus on α7 nicotinic receptor. International Journal of Molecular Sciences. 2021; 22: 4912.

[34] Lin W, Liu T, Wang B, Bi H. The role of ocular dendritic cells in uveitis. Immunology Letters. 2019; 209: 4–10.

[35] Chudnovskiy A, Pasqual G, Victora GD. Studying interactions between dendritic cells and T cells in vivo. Current Opinion in Immunology. 2019; 58: 24–30.

[36] Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nature Reviews Immunology. 2013; 13: 566–577.

[37] Wang G, Li X, Zhang L, Elgaili Abdalla A, Teng T, Li Y. Crosstalk between dendritic cells and immune modulatory agents against sepsis. Genes. 2020; 11: 323.

[38] Kumar V. Dendritic cells in sepsis: potential immunoregulatory cells with therapeutic potential. Molecular Immunology. 2018; 101: 615–626.

[39] Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, Meisel C. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Critical Care. 2009; 13: R119.

[40] Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology. 2003; 109: 365–373.

[41] Guinet E, Yoshida K, Nouri-Shirazi M. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunology Letters. 2004; 95: 45–55.